drugset / Trial / NCT05389176

Effects of Heart Control at Different Stages in Patients of Septic Shock With Tachycardia

NCT05389176

Unknown 96 enrolled Chinese Medical Association
RandomizedParallel-groupDouble-blindTreatment

Summary

A sigle-center, randomized controlled trial will be do to investigate the effects of esomol on heart rate, clinical parameters, mortality, and safety in septic shock patients with tachycardia at different stages, compared with patients who received conventional therapy.

Timeline

Start
2022-07-01
Primary completion
2024-03-31
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmolol Other / unclassified